GoodRx Holdings
Stock Forecast, Prediction & Price Target
GoodRx Holdings Financial Estimates
GoodRx Holdings Revenue Estimates
GoodRx Holdings EBITDA Estimates
GoodRx Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $745.42M N/A | $766.55M 2.83% | $750.26M -2.12% | Avg: $884.30M Low: $856.97M High: $919.40M avg. 17.86% | Avg: $984.37M Low: $961.69M High: $1.00B avg. 11.31% | Avg: $1.12B Low: $1.09B High: $1.15B avg. 13.94% | Avg: $1.29B Low: $1.26B High: $1.32B avg. 15.04% |
Net Income
% change YoY
| $-25.25M N/A | $-32.82M -29.99% | $-8.86M 72.98% | Avg: $87.72M Low: $50.46M High: $127.19M avg. 1089.25% | Avg: $121.75M Low: $82.21M High: $176.07M avg. 38.78% | Avg: $259.86M Low: $252.08M High: $268.57M avg. 113.43% | Avg: $350.81M Low: $340.31M High: $362.57M avg. 35.00% |
EBITDA
% change YoY
| $48.00M N/A | $65.18M 35.79% | $112.92M 73.23% | Avg: $51.10M Low: $49.52M High: $53.13M avg. -54.74% | Avg: $56.88M Low: $55.57M High: $58.35M avg. 11.31% | Avg: $64.82M Low: $63.33M High: $66.49M avg. 13.94% | Avg: $74.57M Low: $72.86M High: $76.50M avg. 15.04% |
EPS
% change YoY
| -$0.06 N/A | -$0.08 -26.19% | -$0.02 72.83% | Avg: $0.21 Low: $0.12 High: $0.31 avg. 1081.94% | Avg: $0.31 Low: $0.2 High: $0.43 avg. 47.84% | Avg: $0.63 Low: $0.61 High: $0.65 avg. 101.96% | Avg: $0.86 Low: $0.83 High: $0.88 avg. 35.00% |
Operating Expenses
% change YoY
| $685.30M N/A | $699.73M 2.10% | $710.34M 1.51% | Avg: $651.10M Low: $630.98M High: $676.95M avg. -8.33% | Avg: $724.78M Low: $708.09M High: $743.47M avg. 11.31% | Avg: $825.86M Low: $806.84M High: $847.16M avg. 13.94% | Avg: $950.14M Low: $928.26M High: $974.65M avg. 15.04% |
FAQ
What is GoodRx Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 319.12% in 2025-2028.
We have gathered data from 10 analysts. Their low estimate is 50.46M, average is 87.72M and high is 127.19M.
What is GoodRx Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 14.54% in 2025-2028.
We have gathered data from 15 analysts. Their low revenue estimate is $856.97M, average is $884.30M and high is $919.40M.
What is GoodRx Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 316.68% in 2025-2028.
We have gathered data from 10 analysts. Their low earnings per share estimate is $0.12, average is $0.21 and high is $0.31.
What is the best performing analyst?
In the last twelve months analysts have been covering GoodRx Holdings stock. The most successful analyst is Craig Hettenbach.